In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and mag...

por Pagano, Paul, Marra, Andrea, Shinabarger, Dean, Pillar, Chris
Publicado 2020

In Vitro Activities of Omadacycline and Comparators against Anaerobic Bacteria

por Stapert, Laure, Wolfe, Cindy, Shinabarger, Dean, Marra, Andrea, Pillar, Chris
Publicado 2018

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis

por Rao, Shasha, Prestidge, Clive A, Miesel, Lynn, Sweeney, Deb, Shinabarger, Dean L, Boulos, Ramiz A
Publicado 2016

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

por Huang, David B., Brothers, Kimberly M., Mandell, Jonathan B., Taguchi, Masashi, Alexander, Peter G., Parker, Dana M., Shinabarger, Dean, Pillar, Chris, Morrissey, Ian, Hawser, Stephen, Ghahramani, Parviz, Dobbins, Despina, Pachuda, Nicholas, Montelaro, Ronald, Steckbeck, Jonathan D., Urish, Kenneth L.
Publicado 2022

Synthetic group A streptogramin antibiotics that overcome Vat resistance

por Li, Qi, Pellegrino, Jenna, Lee, D. John, Tran, Arthur A., Chaires, Hector A., Wang, Ruoxi, Park, Jesslyn E., Ji, Kaijie, Chow, David, Zhang, Na, Brilot, Axel F., Biel, Justin T., van Zundert, Gydo, Borrelli, Kenneth, Shinabarger, Dean, Wolfe, Cindy, Murray, Beverly, Jacobson, Matthew P., Mühle, Estelle, Chesneau, Olivier, Fraser, James S., Seiple, Ian B.
Publicado 2020

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

por Ogunniyi, Abiodun D., Khazandi, Manouchehr, Stevens, Andrew J., Sims, Sarah K., Page, Stephen W., Garg, Sanjay, Venter, Henrietta, Powell, Andrew, White, Karen, Petrovski, Kiro R., Laven-Law, Geraldine, Tótoli, Eliane G., Salgado, Hérida R., Pi, Hongfei, Coombs, Geoffrey W., Shinabarger, Dean L., Turnidge, John D., Paton, James C., McCluskey, Adam, Trott, Darren J.
Publicado 2017

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents

por Tari, Leslie W., Li, Xiaoming, Trzoss, Michael, Bensen, Daniel C., Chen, Zhiyong, Lam, Thanh, Zhang, Junhu, Lee, Suk Joong, Hough, Grayson, Phillipson, Doug, Akers-Rodriguez, Suzanne, Cunningham, Mark L., Kwan, Bryan P., Nelson, Kirk J., Castellano, Amanda, Locke, Jeff B., Brown-Driver, Vickie, Murphy, Timothy M., Ong, Voon S., Pillar, Chris M., Shinabarger, Dean L., Nix, Jay, Lightstone, Felice C., Wong, Sergio E., Nguyen, Toan B., Shaw, Karen J., Finn, John
Publicado 2013